1)Chan CC, Wallace DJ:Intraocular lymphoma:update on diagnosis and management. Cancer Control 11:285-295, 2004
2)Batchelor T, Kolak G, Ciordia R et al:High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 9:711-715, 2003
3)Strauchen JA, Dalton J, Friedman AH:Chemotherapy in the management of intraocular lymphoma. Cancer 63:1918-1921, 1989
4)Sandor V, Stark-Vancs V, Pearson D et al:Phase Ⅱ trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 16:3000-3006, 1998
5)Akpek EK, Ahmed I, Hochberg FH et al:Intraocular-central nervous system lymphoma:clinical features, diagnosis, and outcomes. Ophthalmology 106:1805-1810, 1999
6)Hoffman PM, McKelvie P, Hall AJ et al:Intraocular lymphoma:a series of 14 patients with clinicopathological features and treatment outcomes. Eye 17:513-521, 2003
7)DeAngelis LM, Yahalom J, Thaler HT et al:Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10:635-643, 1992
8)de Smet MD, Vancs VS, Kohler D et al:Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol 83:448-451, 1999
9)Smith JR, Rosenbaum JT, Wilson DJ et al:Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 109:1709-1716, 2002
10)Paulus W:Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neuro-Oncol 43:203-208, 1999
11)平形明人・稲見達也・斉藤真紀・他:眼内悪性リンパ腫における硝子体内インターロイキン-10,インターロイキン-6の診断的価値.日眼会誌 108:359-367,2004
12)Chhanabhai M, Adomat SA, Gascoyne RD et al:Clinical utility of heteroduplex analysis of TCR gamma gene rearrangements in the diagnosis of T-cell lymphoproliferative disorders. Am J Clin Pathol 108:295-301, 1997
13)横田真子・高瀬 博・今井康久・他:眼内悪性リンパ腫が疑われた1例に対する遺伝子解析とサイトカイン測定.日眼会誌 107:287-291,2003